You are visiting a website that is not intended for your region

The page or information you have requested is intended for an audience outside the United States. By continuing to browse you confirm that you are a non-US resident requesting access to this page or information.

Switch to the US site

Denna webbplats använder cookies

Genom att du fortsätter att använda webbplatsen godkänner du att vi använder cookies. Vill du veta mer om hur vi använder cookies och hur du kan hantera dem läs vår integritetspolicy.

Advanta V12

Atrium ADVANTA V12 Balloon Expandable Covered Stent

Advanta V12

Balloon expandable covered stent

Trusted. Reliable. Proven.

Overview

For more than 15 years, by touching over 500,000 lives, our Advanta V12 balloon expandable covered stent has been trusted by physicians for its ease of use and proven, reliable outcomes.

Designed with a unique PTFE covering technology, Advanta V12 inspires confidence with high patency and low reintervention rates.[1] Backed by robust, long-term clinical data and over 450 publications, the Advanta V12 stent continues to prove itself every day.

Indications:

The Advanta V12 balloon expandable covered stent is CE marked and TGA approved for restoring and improving the patency of iliac and renal arteries. Advanta V12 has Canadian Health Ministry license for restoring the patency of iliac lesions. Renal approval is for 5 mm to 7 mm sizes. Advanta V12 is not available in the U.S.

 

 

 

 

PTFE Film Covering Technology

The ultra-thin covering of the Advanta V12 uses a unique, proprietary PTFE film covering technology. The 316L stainless steel struts are completely covered protecting both the flow lumen as well as the struts from contacting the luminal wall. The Advanta V12 is designed to expand uniformly and prevent tissue from prolapsing through the expanded stent.

Product Features

Conformable, deliverable, flexible

 
Designed to track through tortuous arteries and flex to accommodate the iliac and renal anatomy

Low Profile

 
6F & 7F compatibility offers versatility and efficient delivery in complex endovascular procedures

Ability to post-dilate

 
Allows a customized solution to various anatomy*

*Post dilation should always be performed following the guidelines within the Advanta V12 covered stent IFU.

Trusted Design

 

Advanta V12 was designed to conform to the vessel structure, flexible enough to be navigated to the iliac anatomy and to accommodate a 90-degree bend*.

*8-10mm diameters only.

Clinical Data

Cobest study patency graph

COBEST - Randomized Multicenter Study Advanta V12 vs Bare Metal Stents

 
5-Year Data
  • Two-fold lower incidence of re-intervention (p=.02)
  • Significantly higher patency rates at 5 years (74.7% vs. 62.9%; p=.01)[1]
  • Significantly higher patency in subgroup analysis of TASC C/D lesions (p=.003) [1]
iCARUS study 3 year follow-up

iCARUS: Single-Arm IDE Study with 3-Year Follow-Up

 
Freedom from Target Lesion Revascularization (TLR)
  • Real-world patient population with multiple lesions and bilateral disease
  • Study showed sustained clinical benefit with freedom from target lesion revascularization (TLR) up to 3 years[2]

Expert Experience with Advanta V12

COBEST Trial (part 1 of 5)

Learn more about the COBEST (Covered Versus Balloon Expandable Stent Trial) trial from the study’s principal investigator, Professor Patrice Mwipatayi, M.D., head of vascular surgery at Royal Perth Hospital in Perth, Australia.  COBEST was an independent, landmark, prospective, multi center, randomized, controlled clinical trial that demonstrated Getinge’s proprietary balloon expandable covered stent technology is superior to traditional bare metal stents for the treatment of aorto-iliac disease.

COBEST Trial (part 2 of 5)

Learn more about the COBEST (Covered Versus Balloon Expandable Stent Trial) trial from the study’s principal investigator, Professor Patrice Mwipatayi, M.D., head of vascular surgery at Royal Perth Hospital in Perth, Australia.  COBEST was an independent, landmark, prospective, multi center, randomized, controlled clinical trial that demonstrated Getinge’s proprietary balloon expandable covered stent technology is superior to traditional bare metal stents for the treatment of aorto-iliac disease.

COBEST Trial (part 3 of 5)

Learn more about the COBEST (Covered Versus Balloon Expandable Stent Trial) trial from the study’s principal investigator, Professor Patrice Mwipatayi, M.D., head of vascular surgery at Royal Perth Hospital in Perth, Australia.  COBEST was an independent, landmark, prospective, multi center, randomized, controlled clinical trial that demonstrated Getinge’s proprietary balloon expandable covered stent technology is superior to traditional bare metal stents for the treatment of aorto-iliac disease.

COBEST Trial (part 4 of 5)

Learn more about the COBEST (Covered Versus Balloon Expandable Stent Trial) trial from the study’s principal investigator, Professor Patrice Mwipatayi, M.D., head of vascular surgery at Royal Perth Hospital in Perth, Australia.  COBEST was an independent, landmark, prospective, multi center, randomized, controlled clinical trial that demonstrated Getinge’s proprietary balloon expandable covered stent technology is superior to traditional bare metal stents for the treatment of aorto-iliac disease.

COBEST Trial (part 5 of 5)

Learn more about the COBEST (Covered Versus Balloon Expandable Stent Trial) trial from the study’s principal investigator, Professor Patrice Mwipatayi, M.D., head of vascular surgery at Royal Perth Hospital in Perth, Australia.  COBEST was an independent, landmark, prospective, multi center, randomized, controlled clinical trial that demonstrated Getinge’s proprietary balloon expandable covered stent technology is superior to traditional bare metal stents for the treatment of aorto-iliac disease.

Downloads

Alla referenser

  1. 1. Mwipatayi BP, Sharma S, Daneshmand A, et al. Durability of the balloon-expandable covered versus bare-metal stents in the Covered versus Balloon Expandable Stent Trial (COBEST) for the treatment of aortoiliac occlusive disease. J Vasc Surg. 2016. Jul;64(1):83-94.

  2. 2. Laird JR, Loja M, Zeller T, et al. iCAST Balloon-Expandable Covered Stent for Iliac Artery Lesions: 3-Year Results from the iCARUS Multicenter Study. J Vasc Interv Radiol. 2019 Jun;30(6)